Comparing High vs Standard Resolution PET Imaging in Prodromal Parkinson’s Disease

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a single-center, longitudinal imaging study at the Institute for Neurodegenerative Disorders in New Haven, CT. About 25 participants from the PPMI AV-133 prodromal imaging group will undergo a second PET scan using the NeuroEXPLORER camera after receiving [18F] AV-133, in addition to their standard PET scan. Scans occur at baseline, 1 year, and 2 years, with potential additional follow-ups. The study will also correlate imaging results with clinical, biomarker, and genetic data from the PPMI program.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Prodromal participant enrolled in the PPMI 015 sub study.
2. Able to provide consent.

Exclusion Criteria:

a) Any medical or psychiatric condition or lab abnormality that precludes participation per investigators judgement.

Where it's running

• Institute for Neurodegenerative Disorders
  New Haven, Connecticut, United States Recruiting

Study contacts

• Principal investigator: Ken Marek, MD — Institute for Neurodegenerative Disorders
• Study coordinator: Lianne Ramia
• Email: LRamia1@indd.org
• Phone: 203-590-5600

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Early PD signals in people with REM sleep behavior disorder

  This study tests whether people with REM sleep behavior disorder show early signs of Parkinson’s disease before classic symptoms appear.

  Recruiting Danish Research Centre for Magnetic Resonance · Hvidovre · NCT07790744

• Gut-brain in PD Consortium: understanding gut influences in Parkinson's and prodromal stages

  This study tests how the gut and brain communicate in people with Parkinson's, those without PD, and those at risk, to see if gut factors relate to disease onset and progression.

  Recruiting at 4 sites Duke University · Stanford, California and 6 other locations · NCT07567794

• Early longitudinal AV-133 PET imaging in people with prodromal Parkinson's

  This study will try repeated 18F-AV-133 PET scans over two years to track early brain changes in people with prodromal Parkinson's.

  Recruiting at 4 sites Phase 2 Michael J. Fox Foundation for Parkinson's Research · New Haven, Connecticut and 7 other locations · NCT07265596

• Using saliva and extracellular vesicles to diagnose neurodegenerative diseases

  This study is testing a new way to diagnose neurodegenerative diseases like Alzheimer's and Parkinson's by analyzing saliva samples to see if it can help identify these conditions earlier and tailor treatments for patients.

  Recruiting at 5 sites Fondazione Don Carlo Gnocchi ETS · Florence, FI and 4 other locations · NCT06869135

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.